Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs for Premature Ovarian Insufficiency
NCT05308342Unknown
- Start
- Nov 2019
- Primary completion
- Jul 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of human umbilical cord mesenchymal stem cells in premature ovarian insufficiency (POI) (2 arms). Primary endpoint: Follicular development rate. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT05308342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05308342.